GeneOnline’s Top Mergers and Acquisitions of 2019
2019 was a year replete with major pharma, biotech, and digital healthcare deals. Here we highlight some of the major mergers and acquisitions of the year.
The year 2019 began with the big news of Bristol-Myers Squibb (BMS) agreeing to acquire Celgene Corporation for a value of about US$ 74 billion.According to data compiled by Refinitiv,
The year 2019 began with the big news of Bristol-Myers Squibb (BMS) agreeing to acquire Celgene Corporation for a value of about US$ 74 billion.According to data compiled by Refinitiv,